BioSpace News Archive

Pharm Country

Save the Date: HUTCHMED to Present R&D Updates on July 9, 2024

HUTCHMED Limited announces that it will host a R&D update in Shanghai, China, and via webcast on Tuesday, July 9, 2024.

June 24, 2024
·
2 min read
Drug Development

Airway Therapeutics Wins 2024 ATS Whitsett Award for Abstract of Positive Phase 1b Results of Zelpultide Alfa in Preterm Neonates at Risk of Bronchopulmonary Dysplasia

Airway Therapeutics, Inc. announced it received the Whitsett Award for highest scoring abstracts from the Neonatal and Developing Lung Executive Committee at the American Thoracic Society 2024 International Conference.

June 24, 2024
·
3 min read
Genetown

Fractyl Health Announces Advancement in Weight Maintenance Pipeline and Business Updates

Fractyl Health, Inc. announced that it will accelerate its REMAIN-1 clinical study, which is evaluating Revita’s efficacy in maintaining weight loss following the discontinuation of GLP-1 therapy.

June 24, 2024
·
10 min read
Drug Development

G1 Therapeutics Provides Update on Phase 3 PRESERVE 2 Trial in Patients Receiving Trilaciclib Prior to First Line Chemotherapy in Metastatic Triple Negative Breast Cancer (mTNBC)

G1 Therapeutics, Inc., a commercial-stage oncology company, announced topline results from the final OS analysis of its Phase 3 PRESERVE 2 trial evaluating the efficacy and safety of trilaciclib administered prior to chemotherapy in patients with metastatic TNBC.

June 24, 2024
·
6 min read
Bio NC

Asensus Surgical Announces St. Marianna University School of Medicine Yokohama City Seibu Hospital in Japan to Initiate Senhance Surgery Program

Asensus Surgical, Inc. announced that St. Marianna University School of Medicine Yokohama City Seibu Hospital in Japan has entered into an agreement to lease and utilize a Senhance® Surgical System in the Urology and Gastroenterology/General Surgery department.

June 24, 2024
·
5 min read
Policy

TFF Pharmaceuticals Provides Regulatory Update on Tacrolimus Inhalation Powder (TFF TAC) Clinical Program for the Prevention of Lung Transplant Rejection

TFF Pharmaceuticals, Inc. today announced a regulatory update on the Company’s TFF TAC clinical program following its recent interaction with the U.S. Food and Drug Administration (FDA).

June 24, 2024
·
6 min read
Business

OneOncology Partners with Anderson Area Cancer Center

Anderson Area Cancer Center and OneOncology announced a finalized partnership to enhance the delivery of cancer services in and around Anderson, South Carolina.

June 24, 2024
·
2 min read
Drug Development

Viking Therapeutics Presents Preclinical Data on Novel Dual Amylin and Calcitonin Receptor Agonists at 84th Scientific Sessions of the American Diabetes Association

Viking Therapeutics, Inc. today announced the presentation of preclinical data from a series of internally developed dual agonists of the amylin and calcitonin receptors at the 84th Scientific Sessions of the American Diabetes Association.

June 24, 2024
·
6 min read
FDA

iRegene Receives IND approval from U.S. FDA to Start Clinical Trial for Parkinson’s Disease

On June 20 (UTC-4), the U.S. Food and Drug Administration (FDA) approved the IND application for NouvNeu001, a cell therapy product from iRegene therapeutics targeting Parkinson’s Disease.

June 24, 2024
·
4 min read
TiumBio Presents Promising Clinical Data from Phase 1 of its Hemophilia Treatment Candidate TU7710 at ISTH 2024

TiumBio Co., Ltd. announced today that the company presented clinical outcomes of its hemophilia treatment, TU7710, at the 32nd Congress of the International Society on Thrombosis and Haemostasis (ISTH) and embarked on building new global partnerships.

June 24, 2024
·
3 min read